RTW INVESTMENTS, LP Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$6.6B
Holdings
120
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (120 positions)
| Stock | Value |
|---|---|
RCKTROCKET PHARMACEUTICALS INC | $469.6M |
SPYSPDR S&P 500 ETF TR | $374.7M |
ALNYALNYLAM PHARMACEUTICALS INC | $317.8M |
MRTXEURMIRATI THERAPEUTICS INC | $264.0M |
TMOTHERMO FISHER SCIENTIFIC INC | $237.7M |
3M4MASIMO CORP | $225.4M |
VCELVERICEL CORP | $220.5M |
TCE2CELLDEX THERAPEUTICS INC NEW | $211.0M |
NTRANATERA INC | $207.5M |
PTCTPTC THERAPEUTICS INC | $197.0M |
ILMNILLUMINA INC | $195.8M |
ESTAESTABLISHMENT LABS HLDGS INC | $166.0M |
—DICERNA PHARMACEUTICALS INC | $152.9M |
TNDMTANDEM DIABETES CARE INC | $138.6M |
GMEDGLOBUS MED INC | $128.0M |
AXNX*AXONICS INC | $126.5M |
RNAAVIDITY BIOSCIENCES INC | $118.1M |
GHGUARDANT HEALTH INC | $115.7M |
CCCCC4 THERAPEUTICS INC | $111.5M |
OPHTEURIVERIC BIO INC | $109.2M |
FULCFULCRUM THERAPEUTICS INC | $108.8M |
TXG10X GENOMICS INC | $106.9M |
PENPENUMBRA INC | $102.7M |
DMTKQDERMTECH INC | $100.1M |
STOKSTOKE THERAPEUTICS INC | $92.7M |
IDYAIDEAYA BIOSCIENCES INC | $83.3M |
MGNXMACROGENICS INC | $83.2M |
—PROMETHEUS BIOSCIENCES INC | $77.4M |
RGNXREGENXBIO INC | $77.4M |
CYTKCYTOKINETICS INC | $71.5M |
5E7ITEOS THERAPEUTICS INC | $63.5M |
—LANDOS BIOPHARMA INC | $62.4M |
CUTREURCUTERA INC | $58.6M |
AVDLAVADEL PHARMACEUTICALS PLC | $56.3M |
PRQRPROQR THRAPEUTICS N V | $53.9M |
AXSMAXSOME THERAPEUTICS INC | $53.3M |
TNYATENAYA THERAPEUTICS INC | $48.6M |
AGENEURAGENUS INC | $47.6M |
APYXAPYX MEDICAL CORPORATION | $47.1M |
IMCRIMMUNOCORE HLDGS PLC | $46.2M |
GHRSGH RESEARCH PLC | $45.7M |
OMGBPOUTSET MED INC | $44.2M |
TARSTARSUS PHARMACEUTICALS INC | $43.4M |
ARGXARGENX SE | $42.4M |
LUNGPULMONX CORP | $41.9M |
RLMDRELMADA THERAPEUTICS INC | $40.3M |
CSTLCASTLE BIOSCIENCES INC | $39.8M |
NSTGEURNANOSTRING TECHNOLOGIES INC | $38.6M |
—OLINK HLDG AB | $32.0M |
PTGXPROTAGONIST THERAPEUTICS INC | $31.1M |
BLUBELLUS HEALTH INC NEW | $30.4M |
SGHTSIGHT SCIENCES INC | $29.1M |
JNJJOHNSON & JOHNSON | $27.5M |
GLUEMONTE ROSA THERAPEUTICS INC | $26.0M |
CLSDUSDCLEARSIDE BIOMEDICAL INC | $25.2M |
MISTMILESTONE PHARMACEUTICALS IN | $24.6M |
PMVPPMV PHARMACEUTICALS INC | $24.1M |
—GENETRON HLDGS LTD | $23.2M |
OYSTOYSTER PT PHARMA INC | $22.1M |
WHWKAADI BIOSCIENCES INC | $21.3M |
EPIEURESSA PHARMA INC | $21.1M |
I9DNARBUTUS BIOPHARMA CORP | $20.3M |
INMDINMODE LTD | $19.9M |
CERE1EURCEREVEL THERAPEUTICS HLDNG I | $19.7M |
—RENOVACOR INC | $19.3M |
TELATELA BIO INC | $19.0M |
—ATHIRA PHARMA INC | $17.9M |
ADVMCHFADVERUM BIOTECHNOLOGIES INC | $16.2M |
NEONEOGENOMICS INC | $14.9M |
URGNUROGEN PHARMA LTD | $14.4M |
EP3ORASURE TECHNOLOGIES INC | $13.3M |
BWAYBRAINSWAY LTD | $12.9M |
IMUXIMMUNIC INC | $12.1M |
—VINCERX PHARMA INC | $12.1M |
XGNEXAGEN INC | $11.2M |
CNTBCONNECT BIOPHARMA HLDGS LTD | $10.9M |
JNCEEURJOUNCE THERAPEUTICS INC | $10.4M |
NYXHNYXOAH S A | $10.1M |
BMEABIOMEA FUSION INC | $9.9M |
—LIFESCI ACQUISITION II CORP | $9.6M |
—LA JOLLA PHARMACEUTICAL CO | $9.3M |
TNGXTANGO THERAPEUTICS INC | $7.8M |
PRCTPROCEPT BIOROBOTICS CORP | $7.4M |
MLTXHELIX ACQUISITION CORP | $7.4M |
CTMXCYTOMX THERAPEUTICS INC | $7.1M |
NAUTNAUTILUS BIOTECHNOLOGY INC | $6.6M |
—RESEARCH ALLIANCE CORP II | $6.3M |
—BCLS ACQUISITION CORP | $6.1M |
—ASLAN PHARMACEUTICALS LTD | $5.8M |
SRRKSCHOLAR ROCK HLDG CORP | $5.3M |
SOPHSOPHIA GENETICS SA | $5.3M |
BLIUSDBERKELEY LTS INC | $5.0M |
—SUMMIT HEALTHCRE ACQUISTN CO | $5.0M |
—ARYA SCIENCES ACQU CORP IV | $5.0M |
RCELAVITA MEDICAL INC | $5.0M |
—ARYA SCIENCES ACQUISITN CORP | $4.9M |
IMTXIMMATICS N.V | $4.5M |
AFIBACUTUS MED INC | $4.3M |
APVOAPTEVO THERAPEUTICS INC | $4.3M |
—5 01 ACQUISITION CORP | $3.8M |
Page 1 of 2Next